IMPLEMENT NEW TECHNOLOGIES

THAT LEAD TO ENHANCED PATIENT COMPLIANCE AND IMPROVED TREATMENTS

 
 

CAPITALIZE ON PRIOR SUCCESSES

AND CURRENT OPPORTUNITIES TO DEVELOP A DIVERSE PORTFOLIO OF GENERIC AND BRANDED DRUGS

 
 

FOCUS ON PRODUCTS

WHICH PROVIDE REAL VALUE AND BENEFITS TO PATIENTS AROUND THE WORLD

Recent News

Kitov Signs Marketing and Distribution Agreement for its Lead Product Consensi™ in the U.S. with Coeptis Pharmaceuticals

| Press Releases | One Comment
Coeptis Pharmaceuticals, Inc. has announced today that it has signed an exclusive marketing and distribution agreement with Kitov Pharmaceuticals for Consensi™ in the U.S. market.

Coeptis Pharma Enters into Agreement to Acquire Elto Pharma

| Press Releases | One Comment
Coeptis Pharmaceuticals, Inc. today announced that it has entered into a binding agreement to acquire all outstanding shares of Elto Pharma, Inc.

Coeptis Pharmaceuticals Signs Multi-product Development Agreement With Vici Health Sciences

| Press Releases | No Comments
Coeptis Pharmaceuticals, Inc announced today that it has entered into a multi-product agreement with Vici Health Sciences under which Coeptis and Vici expect to develop and commercialize several generic and 505(b)(2) products.

About Us

Coeptis Pharmaceuticals, Inc. is a privately held biopharmaceutical company engaged in the acquisition, development and commercialization of branded pharmaceutical products. The company owns an expansive portfolio of 505(b)(2) assets, various novel small molecule therapies for neurological based indications and biotechnology assets, which includes a stake in an immuno-discovery company with platform RNA modulation technologies for optimized gene and cell therapies with a focus on cancers, encompassing a wide array of treatments such as CAR-T and CAR-NK.  Headquartered near Pittsburgh, PA, Coeptis Pharmaceuticals holds a robust pipeline of products in various stages of development and commercialization.

Our emphasis are products that present unique opportunities for the healthcare community. We work across all therapeutic areas to identify, develop, and commercialize products that are marketed to retail and non-retail prescription drug channels.

Our Approach

  1. Focus on opportunities and innovation.
  2. Create valuable partnerships with world class companies that excel on quality, value, and environmental stewardship.
  3. Staff of superstars. Our strength comes from our committed team of dedicated professionals.
  4. Commitment to patients. Our products help to lower drug prices and reduce overall healthcare costs for our patients.